01 1Boehringer Ingelheim Pharma GmbH and Co. KG
02 1Eurofins CDMO Alphora Inc
01 1ZONGERTINIB
02 1Zongertinib
01 2Blank
NDC Package Code : 43076-031
Start Marketing Date : 2025-08-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 12714-301
Start Marketing Date : 2025-09-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
17
PharmaCompass offers a list of Zongertinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zongertinib manufacturer or Zongertinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zongertinib manufacturer or Zongertinib supplier.
PharmaCompass also assists you with knowing the Zongertinib API Price utilized in the formulation of products. Zongertinib API Price is not always fixed or binding as the Zongertinib Price is obtained through a variety of data sources. The Zongertinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zongertinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zongertinib, including repackagers and relabelers. The FDA regulates Zongertinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zongertinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zongertinib supplier is an individual or a company that provides Zongertinib active pharmaceutical ingredient (API) or Zongertinib finished formulations upon request. The Zongertinib suppliers may include Zongertinib API manufacturers, exporters, distributors and traders.
click here to find a list of Zongertinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zongertinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zongertinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zongertinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zongertinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zongertinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zongertinib suppliers with NDC on PharmaCompass.
